KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,429,842 | -39.5% | 5,858,262 | 0.0% | 12.61% | -24.8% |
| Q2 2023 | $134,681,443 | -22.4% | 5,858,262 | 0.0% | 16.76% | -28.7% |
| Q1 2023 | $173,580,303 | +16.2% | 5,858,262 | -2.1% | 23.50% | +30.6% |
| Q4 2022 | $149,379,011 | -0.2% | 5,984,736 | -13.0% | 17.99% | +8.9% |
| Q3 2022 | $149,684,000 | +10.6% | 6,875,698 | 0.0% | 16.52% | -27.0% |
| Q2 2022 | $135,382,000 | -53.5% | 6,875,698 | 0.0% | 22.63% | -38.5% |
| Q1 2022 | $290,980,000 | -33.3% | 6,875,698 | 0.0% | 36.79% | -8.3% |
| Q4 2021 | $436,538,000 | – | 6,875,698 | – | 40.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |